Proposed Cardiac End Points for Clinical Trials in Immunoglobulin Light Chain Amyloidosis: Report From the Amyloidosis Forum Cardiac Working Group

Immunoglobulin light chain amyloidosis is a rare, multisystemic, phenotypically heterogenous disease affecting cardiovascular, renal, neurological, and gastrointestinal systems to varying degrees. Its underlying cause is a plasma cell dyscrasia characterized by misfolding of monoclonal immunoglobuli...

Descripción completa

Detalles Bibliográficos
Autores principales: Maurer, Mathew S., Dunnmon, Preston, Fontana, Mariana, Quarta, Cristina Candida, Prasad, Krishna, Witteles, Ronald M., Rapezzi, Claudio, Signorovitch, James, Lousada, Isabelle, Merlini, Giampaolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Advances in Heart Failure, Mechanical Circulatory Support and Transplant
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202961/
https://www.ncbi.nlm.nih.gov/pubmed/35331001
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.121.009038

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202961/
https://www.ncbi.nlm.nih.gov/pubmed/35331001
http://dx.doi.org/10.1161/CIRCHEARTFAILURE.121.009038

Ejemplares similares